to main content Contrast Agents – Guidance for Managing Shortages and Conservation | Ambulatory | Medication Management MM | The Joint Commission
Contrast Agents – Guidance for Managing Shortages and Conservation

What options are available for organizations to consider as they manage the impact of the critical shortage of intravenous contrast agents?

Any examples are for illustrative purposes only. 

The American Society of Health-System Pharmacists (ASHP) recently published a resource titled "Considerations for Imaging Contrast Shortage Management and Conservation" which is consistent with our current accreditation requirements. Organizations are encouraged to review this document which provides guidance in shortage management and conservation.
Manual: Ambulatory
Chapter: Medication Management MM
New or updated requirements last added: May 16, 2022. New or updated requirements may be based on revisions to current accreditation requirements, regulatory changes, and/or an updated interpretation in response to industry changes. Substantive changes to accreditation requirements are also published in the Perspective Newsletter that is available to all Joint Commission accredited organizations.
Last reviewed by Standards Interpretation: May 16, 2022 Represents the most recent date that the FAQ was reviewed (e.g. annual review).
This page was last updated on May 16, 2022 with update notes of: Reflects new or updated requirements Types of changes and an explanation of change type: Editorial changes only: Format changes only. No changes to content. | Review only, FAQ is current: Periodic review completed, no changes to content. | Reflects new or updated requirements: Changes represent new or revised requirements.

If no, please comment on how we could improve this response.

If you have additional standards-related questions regarding this topic, please use the Standards Online Submission Form